News Focus
News Focus
Post# of 257426
Next 10
Followers 2
Posts 277
Boards Moderated 0
Alias Born 09/19/2007

Re: DewDiligence post# 186590

Monday, 01/26/2015 12:33:41 PM

Monday, January 26, 2015 12:33:41 PM

Post# of 257426
Unless ESRX is doing outreach to HCV patients, the 92/8 split is surely a reasonable first approximation of patients in treatment non-ESRX/ESRX.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today